The DVD is an informative tool for GPs and paediatricians as well as providing an easily understood explanation of coeliac disease for family, classmates and friends.

Thank you to those who made the developent of the CD possible, the Zig Inge Foundation, Nexpep, Associate Professor Don Cameron, Avril Brereton and Graham Cumming Multi Media.

You can download or order on line by clicking here.

We extend our gratitude to the Helen Macpherson Smith Trust for their support of our planned Educational Outreach Programs in collaboration with The Coeliac Society Victoria. 

Recognising the need to develop a high calibre educational outreach program to disseminate key, up-to-date messages about coeliac disease, the CRF and CSVic have combined to ensure delivery of four educational programs each comprising a general public session and one designed for GPs and allied health professionals.  Programs will be delivered in the western suburbs, eastern suburbs, Bairnsdale and Warnambool and will form the basis of an educational model which can be delivered interstate.

Now that funding has generously been agreed by the Helen Macpherson Smith Trust, we can begin planning in earnest for this exciting new project - watch this space for upcoming dates and venues.

The upgrade would not have been possible without this generous input and advice.

End-to-end, EraseIT provides quality assurance for the secure and ethical disposal of retired computer assets in a fully compliant environment.  EraseIT was established to meet increasing customer demand and to complement Interactive’s existing Hardware Maintenance, Data Centre and Managed Services. The organisation offers peace of mind through its end-to-end secure solution for eliminating risks associated with the disposal of IT data and infrastructure. EraseIT is 100% Australian owned.

Click here to visit EraseIT’s website.

The CRF is taking orders for copies of Markku Mäki’s presentation in Melbourne. The DVD provides 40 minutes of insight into coelaic disease and exciting new research findings, presented by Professor Mäki.

The cost of the DVD is $20 - hurry, we are placing orders soon!!

Download order form.

Please contact Mandy on 1300 990 273 or email admin@coeliacresearchfund.org for further information.

Professor Maki is one of the innovative opinion leaders in the field worldwide. More than two decades ago, he joined the Finnish Coeliac Society and his research has been inspired by the needs of the coeliac sufferers. The outcome of his group research is the understanding of the broad clinical spectrum of gluten-induced disease entities, the correct use of serologic biomarker tests and a rapid point of care test in the primary health care, leading to a 20-fold increase of diagnosed coeliac disease in adults in Finland. His academic group is collaborating in addition to the patient organisations also with the authorities and industry. He was elected as the President of the nationwide Finnish Coeliac Society, and he is still today the Chairman of the Scientific Advisory Board. Professor Markku Maki is a permanent member of the Finnish Academy of Science and Letters and the President of Finland has granted him the honour of Knight, First Class, of the Order of the White Rose of Finland in 2006.

Thank you to our breakfast sponsors

Integrated Sciences, Werfen Group, Inova Diagnostics and Nexpep Pty Ltd

Awareness Principle Partner Coles Supermarkets

The diagnostic card is a useful resource for those diagnosing coeliac disease and for those seeking an answer to whether they have the condition or not.   It has a simple explanation of some of the symptoms of coeliac disease and has been developed by our Clinical Advisory Committee.  Follow the gold standard of diagnosis and ensure correct testing is undertaken.

EMAIL info@coeliacresearchfund.org

with your contact details then we can arrange a supply for you

(name, address, telephone number please)

Alternatively, you can download the card by clicking on the image.

Coles are our Principal Campaign Partners of Coeliac Awareness 2010-2011.

Coles have a large range of gluten free products to assist in following a strict gluten free diet. From Pantry essentials to indulgent treats, we are constantly improving our range to deliver a variety of delicious gluten free alternatives located in the Freezer, Bakery and Health Food aisles of your local Coles Supermarket.

Click here to go to the Coles Supermarket’s website

Click here for the new Gluten Free Page on the Coles website

This treatment approach to an immune disease is not unique, and there is sufficient evidence of desensitisation in other disorders. This approach may lead Nexpep to expand it’s development into therapies for other autoimmune disorders in the future.  Nexpep is in a unique position, holding the relevant patents to diagnostics and treatments utilising the gluten peptides recognised by T cells in coeliac disease. No other group or company is pursuing peptide immunotherapy for coeliac disease.

Nexpep’s main product, Nexvax2, is a unique immune-focussed therapy for coeliac disease. The aim of Nexvax2 is to desensitise a coeliac disease patient’s immune system to gluten so that a state of “gluten tolerance” is achieved - analagous to traditional desensitisation regimens for several allergic diseases. Nexvax2 is comprised of select gluten fragments called peptides, and it is envisaged that Nexvax2 would be administered as a series of injections. A study to test the safety of Nexvax2 (phase 1 trial) is well underway (see: http://clinicaltrials.gov/ct2/show/NCT00879749), with results expected in the middle of 2010. The main aim of this early trial is to determine the safety of Nexvax2 in people with coeliac disease. Additional studies will be performed on Nexvax2 to establish the optimal dose and how effective it is.

As more information becomes available it will be posted on our website. If you would like more information about Nexpep Pty Ltd please contact Nexpep CEO Dr Bob Anderson. Visit our website http://www.nexpep.com

Nexpep’s research and development program was performed at The Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, Australia, under a collaborative research agreement between Nexpep, WEHI and the Royal Melbourne Hospital / Melbourne Health.

Inova Diagnostics and The Werfen Group, in association Integrated Sciences, realised the importance of a visit by a world leader in coeliac disease research to Australia. 

Inova is one of the world leaders in autoimmune disease diagnostics

INOVA is dedicated exclusively to autoimmune diagnostics. They offer quality on a comprehensive range of autoimmune testing reagents  and provide technical proficiency, product support and service to their customers.

A History of innovation

INOVA Diagnostics, Inc. was formed in 1987 by a group of scientists who were directly involved in the early development of autoimmune disease serology as well as the people responsible for the first commercially available autoantibody test kits. INOVA Diagnostics has a rich history of innovative and first FDA-cleared products focused on the diagnosis of autoimmune diseases such as coeliac disease, rheumatoid arthritis, and systemic lupus erythematosus among others.

In July 2009, Werfen Group successfully completed the acquisition of the autoimmune disease diagnostics business of The Binding Site Group Ltd.  The Binding Site autoimmune disease test portfolio complements the INOVA Diagnostics’ family of products and nearly doubles the total portfolio to over 400 products and systems.

Today, INOVA is recognized worldwide as a leader in autoimmune disease diagnostics. The majority of their products are produced in their Scripps Ranch facility located in the heart of Southern California’s Biotechnology community. They combine administration, R&D and manufacturing under one roof, which provides reliable and economical solutions  for all of their autoimmune disease testing needs.

Visit their website: http://www.inovadx.com

Integrated Sciences supported the visit of Professor Markku Mäki to Australia for Coeliac Awareness Week 2010.

The visit of Professor Mäki would not have been possible without the generous support of Integrated Sciences (and Inova).  Their understanding of the coeliac disease landscape has made possible a visit by a world leader in coeliac disease research to Australia and is a very important milestone.  It means we are serious about making a difference.  Integrated Sciences is partnering the CRF in our vision and we know they are as committed as we are to changing outcomes for those with coeliac disease, both diagnosed and undiagnosed.

Integrated Sciences Pty Ltd, established 1983 is an Australian owned business that supplies both the Australian Diagnostics and Life Science markets. Their staff are scientifically qualified and embrace the organisations’s values of integrity and excellence in all they do. Integrated Sciences has welcomed being affiliated with Coeliac Awareness Week through their representation of the INOVA Diagnostics/Werfen products. INOVA Diagnostics is a recognised worldwide leader in autoimmune disease diagnostics with particular interest in the importance of correct serological diagnosis of Coeliac Disease & ongoing serological maintenance. Their highly rapid and specific Coeliac diagnostic kits provide non-invasive diagnosis and disease monitoring.

It is absolutely critical that this disease is diagnosed and managed correctly through consultation with your physician.

 Click here to go to the Integrated Sciences website.